129 related articles for article (PubMed ID: 8387927)
1. Clozapine and N-desmethylclozapine are potent 5-HT1C receptor antagonists.
Kuoppamäki M; Syvälahti E; Hietala J
Eur J Pharmacol; 1993 Apr; 245(2):179-82. PubMed ID: 8387927
[TBL] [Abstract][Full Text] [Related]
2. Chronic clozapine treatment decreases 5-hydroxytryptamine1C receptor density in the rat choroid plexus: comparison with haloperidol.
Kuoppamäki M; Seppälä T; Syvälahti E; Hietala J
J Pharmacol Exp Ther; 1993 Mar; 264(3):1262-7. PubMed ID: 8383744
[TBL] [Abstract][Full Text] [Related]
3. 5-HT1C receptor-mediated phosphoinositide hydrolysis in the rat choroid plexus after chronic treatment with clozapine.
Kuoppamäki M; Pälvimäki EP; Syvälahti E; Hietala J
Eur J Pharmacol; 1994 Apr; 255(1-3):91-7. PubMed ID: 8026557
[TBL] [Abstract][Full Text] [Related]
4. Regulation of serotonin 5-HT2C receptors in the rat choroid plexus after acute clozapine treatment.
Kuoppamäki M; Seppälä T; Syvälahti E; Hietala J
Eur J Pharmacol; 1994 Oct; 269(2):201-8. PubMed ID: 7851496
[TBL] [Abstract][Full Text] [Related]
5. Modulation of 5-HT1C receptors and phosphoinositide system by ethanol consumption in rat brain and choroid plexus.
Pandey SC; Dubey MP; Piano MR; Schwertz DW; Davis JM; Pandey GN
Eur J Pharmacol; 1993 Sep; 247(1):81-8. PubMed ID: 8258364
[TBL] [Abstract][Full Text] [Related]
6. 5-HT1C receptors mediate phosphoinositide turnover activation in the immature rat hippocampus.
Claustre Y; Eudeline B; Benavides J; Scatton B
Eur J Pharmacol; 1992 Jan; 225(1):37-41. PubMed ID: 1311687
[TBL] [Abstract][Full Text] [Related]
7. 5-HT-induced transferrin production by choroid plexus epithelial cells in culture: role of 5-HT1c receptor.
Tsutsumi M; Sanders-Bush E
J Pharmacol Exp Ther; 1990 Jul; 254(1):253-7. PubMed ID: 2164094
[TBL] [Abstract][Full Text] [Related]
8. Competitive antagonism by recognized 5-HT2 receptor antagonists at 5-HT1C receptors in pig choroid plexus.
Sahin-Erdemli I; Schoeffter P; Hoyer D
Naunyn Schmiedebergs Arch Pharmacol; 1991 Aug; 344(2):137-42. PubMed ID: 1944609
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of N-desmethylclozapine as a potential antipsychotic--preclinical studies.
Natesan S; Reckless GE; Barlow KB; Nobrega JN; Kapur S
Neuropsychopharmacology; 2007 Jul; 32(7):1540-9. PubMed ID: 17164815
[TBL] [Abstract][Full Text] [Related]
10. Serotonin agonists increase transferrin levels via activation of 5-HT1C receptors in choroid plexus epithelium.
Esterle TM; Sanders-Bush E
J Neurosci; 1992 Dec; 12(12):4775-82. PubMed ID: 1334504
[TBL] [Abstract][Full Text] [Related]
11. The binding of SCH 39166 and SCH 23390 to 5-HT1C receptors in porcine choroid plexus.
Taylor LA; Tedford CE; McQuade RD
Life Sci; 1991; 49(20):1505-11. PubMed ID: 1943454
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of rat 5-HT2A and 5-HT2C receptors after chronic treatment with clozapine, chlorpromazine and three putative atypical antipsychotic drugs.
Kuoppamäki M; Pälvimäki EP; Hietala J; Syvälahti E
Neuropsychopharmacology; 1995 Oct; 13(2):139-50. PubMed ID: 8597525
[TBL] [Abstract][Full Text] [Related]
13. The clozapine metabolite N-desmethylclozapine displays variable activity in diverse functional assays at human dopamine D₂ and serotonin 5-HT₁A receptors.
Heusler P; Bruins Slot L; Tourette A; Tardif S; Cussac D
Eur J Pharmacol; 2011 Nov; 669(1-3):51-8. PubMed ID: 21835172
[TBL] [Abstract][Full Text] [Related]
14. Further evidence for clozapine as a dopamine D1 receptor agonist.
Salmi P; Ahlenius S
Eur J Pharmacol; 1996 Jun; 307(1):27-31. PubMed ID: 8831100
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological profile of AD-5423, a novel antipsychotic with both potent dopamine-D2 and serotonin-S2 antagonist properties.
Oka M; Noda Y; Ochi Y; Furukawa K; Une T; Kurumiya S; Hino K; Karasawa T
J Pharmacol Exp Ther; 1993 Jan; 264(1):158-65. PubMed ID: 8093723
[TBL] [Abstract][Full Text] [Related]
16. N-Desmethylclozapine exerts dual and opposite effects on salivary secretion in the rat.
Ekström J; Godoy T; Riva A
Eur J Oral Sci; 2010 Feb; 118(1):1-8. PubMed ID: 20156258
[TBL] [Abstract][Full Text] [Related]
17. Serotonin1c receptor reserve in choroid plexus masks receptor subsensitivity.
Sanders-Bush E; Breeding M
J Pharmacol Exp Ther; 1990 Mar; 252(3):984-8. PubMed ID: 2319481
[TBL] [Abstract][Full Text] [Related]
18. Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release.
Cosi C; Carilla-Durand E; Assié MB; Ormiere AM; Maraval M; Leduc N; Newman-Tancredi A
Eur J Pharmacol; 2006 Mar; 535(1-3):135-44. PubMed ID: 16554049
[TBL] [Abstract][Full Text] [Related]
19. Antagonism by SCH 23390 of clozapine-induced hypothermia in the rat.
Salmi P; Karlsson T; Ahlenius S
Eur J Pharmacol; 1994 Feb; 253(1-2):67-73. PubMed ID: 7912199
[TBL] [Abstract][Full Text] [Related]
20. Antipsychotic effects of N-desmethylclozapine on sensorimotor gating function in rats--possible involvement of activation of M(1) muscarinic receptors.
Maehara S; Satow A; Hikichi H; Ohta H
Eur J Pharmacol; 2011 Sep; 667(1-3):242-9. PubMed ID: 21658379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
